T 593

03/01/1999 - "Therefore, T-593 improves the quality of ulcer healing."
12/01/1998 - "In the histological measurement, the grades of heterotopic regenerated gland and inflammatory cell infiltration of T-593 was lower than those of the control and other drugs in the ulcer area. "
08/01/1998 - "This interesting property of T-593 is expected to contribute to the clinical promotion of ulcer healing."
08/01/1998 - "This interesting property of T-593 is expected to raise the quality of ulcer healing (QOUH) and also may prevent ulcer recurrence."
12/01/1998 - "From these results, it is concluded that T-593 induces ulcer healing with a lower recurrence and/or relapse rate of ulcers than other conventional H2-antagonists, and T-593 may thus be a useful anti-ulcer drug for clinical therapy."

03/01/1999 - "[Histological study on healing of cryocautery-induced rat gastric ulcer treated with T-593]."
12/01/1998 - "[Influence of T-593 on the recurrence and relapse of cryocautery-induced gastric ulcer in rats: sequential observation with an endoscope and histological evaluation]."
02/01/1996 - "Spontaneous healing of kissing gastric ulcers was significantly enhanced when T-593 was administered for 14 days. "
08/01/1998 - "Chronic gastric ulcer induced by acetic acid was, however, not healed by the sole treatment of each optical isomer, while racemic T-593 showed a significant effect. "
03/01/1999 - "The effect of T-593, a novel anti-ulcer agent, on the healing of cryocautery-induced rat gastric ulcer was investigated histologically in comparison with that of famotidine. "

03/01/1998 - "Additional notable features of T-593, as determined in rats, are that its protective effect on the hemorrhagic shock-induced lesion under the prior dosing of histamine is ca. 10- and 2-fold greater than ranitidine and famotidine, respectively, and that a decrease in the gastric mucosal blood flow caused by a partial blood-withdrawal is more strongly recovered with T-593 than with famotidine. "

02/01/1996 - "Spontaneous healing of kissing gastric ulcers was significantly enhanced when T-593 was administered for 14 days. "

06/01/2012 - "SU-E-T-593: VMAT Vs. IMRT for Treatment of Neoplasms of the Brain: Dosimetric Quality and Delivery."